Gilead Sciences, Inc.

Biotechnology & Medical Research

Company Summary

Gilead Sciences, Inc., a biopharmaceutical business centred on research, discovers, develops, and commercialises medications in areas of unmet medical need in the United States, Europe, and other parts of the world. The company is based in Foster City, California, and was founded in 1987.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

22
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E0S14G8.2

Refinitiv

Overall ESG Rating :

76
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E39S97G82

Overall ESG Rating :

AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Gilead is a leader among 41 companies in the biotechnology industry.

Temperature Rise :

1.57℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned